These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8961212)

  • 1. The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
    Feldmann M
    J R Coll Physicians Lond; 1996; 30(6):560-70. PubMed ID: 8961212
    [No Abstract]   [Full Text] [Related]  

  • 2. The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.
    Campion GV
    Ann Rheum Dis; 1994 Aug; 53(8):485-7. PubMed ID: 7944630
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental therapy of rheumatoid arthritis with antibodies to tumor necrosis factor].
    Manger B
    Z Rheumatol; 1998 Oct; 57(5):298-301. PubMed ID: 9864834
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
    J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
    Butler DM; Maini RN; Feldmann M; Brennan FM
    Eur Cytokine Netw; 1995; 6(4):225-30. PubMed ID: 8789287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysing the effect of novel therapies on cytokine expression in experimental arthritis.
    Williams RO; Inglis JJ; Simelyte E; Criado G; Sumariwalla PF
    Int J Exp Pathol; 2005 Oct; 86(5):267-78. PubMed ID: 16191099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatments no longer in development for rheumatoid arthritis.
    Keystone E
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii43-5. PubMed ID: 12379620
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of anti-TNF therapy for rheumatoid arthritis.
    Feldmann M
    Nat Rev Immunol; 2002 May; 2(5):364-71. PubMed ID: 12033742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 12. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
    Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
    Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
    Gerlag DM; Tak PP
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
    Maini RN; Brennan FM; Williams R; Chu CQ; Cope AP; Gibbons D; Elliott M; Feldmann M
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S173-5. PubMed ID: 8391952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
    Elliott MJ; Feldmann M; Maini RN
    Int J Immunopharmacol; 1995 Feb; 17(2):141-5. PubMed ID: 7544768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D; Toussirot E
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract]   [Full Text] [Related]  

  • 18. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of TNF-α with a focus on rheumatoid arthritis.
    Moelants EA; Mortier A; Van Damme J; Proost P
    Immunol Cell Biol; 2013 Jul; 91(6):393-401. PubMed ID: 23628802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.